Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
53.90
+3.96 (7.93%)
At close: May 12, 2025, 4:00 PM
54.96
+1.06 (1.97%)
After-hours: May 12, 2025, 7:56 PM EDT
Bio-Techne Employees
Bio-Techne had 3,050 employees as of June 30, 2023. The number of employees increased by 50 or 1.67% compared to the previous year.
Employees
3,050
Change (1Y)
50
Growth (1Y)
1.67%
Revenue / Employee
$396,318
Profits / Employee
$43,162
Market Cap
8.45B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 3,050 | 50 | 1.67% |
Jun 30, 2022 | 3,000 | 400 | 15.38% |
Jun 30, 2021 | 2,600 | 300 | 13.04% |
Jun 30, 2020 | 2,300 | 50 | 2.22% |
Jun 30, 2019 | 2,250 | 250 | 12.50% |
Jun 30, 2018 | 2,000 | 200 | 11.11% |
Jun 30, 2017 | 1,800 | 240 | 15.38% |
Jun 30, 2016 | 1,560 | 204 | 15.04% |
Jun 30, 2015 | 1,356 | 335 | 32.81% |
Jun 30, 2014 | 1,021 | 167 | 19.56% |
Jun 30, 2013 | 854 | 7 | 0.83% |
Jun 30, 2012 | 847 | 13 | 1.56% |
Jun 30, 2011 | 834 | 97 | 13.16% |
Jun 30, 2010 | 737 | -9 | -1.21% |
Jun 30, 2009 | 746 | 27 | 3.76% |
Jun 30, 2008 | 719 | 38 | 5.58% |
Jun 30, 2007 | 681 | 44 | 6.91% |
Jun 30, 2006 | 637 | 28 | 4.60% |
Jun 30, 2005 | 609 | 12 | 2.01% |
Jun 30, 2004 | 597 | 11 | 1.88% |
Jun 30, 2003 | 586 | 16 | 2.81% |
Jun 30, 2002 | 570 | 9 | 1.60% |
Jun 30, 2001 | 561 | 64 | 12.88% |
Jun 30, 2000 | 497 | 26 | 5.52% |
Jun 30, 1999 | 471 | 60 | 14.60% |
Jun 30, 1998 | 411 | 46 | 12.60% |
Jun 30, 1997 | 365 | -7 | -1.88% |
Jun 30, 1996 | 372 | 28 | 8.14% |
Jun 30, 1995 | 344 | 67 | 24.19% |
Jun 30, 1994 | 277 | 71 | 34.47% |
Jun 30, 1993 | 206 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TECH News
- 16 hours ago - Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025 - PRNewsWire
- 4 days ago - Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing - PRNewsWire
- 4 days ago - Bio-Techne to Present at the BofA Securities 2025 Health Care Conference - PRNewsWire
- 5 days ago - Bio-Techne Corporation (TECH) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Bio-Techne exceeds profit expectations, announces new share buyback plan - Reuters
- 5 days ago - BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM - PRNewsWire
- 5 days ago - BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS - PRNewsWire
- 6 days ago - ScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc. - PRNewsWire